Tag School of Pharmacy
UW–Madison leading new research collaboration aimed at treating lung scarring diseases
An interdisciplinary group of researchers will will investigate the biological processes that promote lung scarring. With the aid of artificial intelligence and advanced 3D modeling, they will also develop and refine new imaging techniques and drug delivery systems that could aid in halting its progression.
Pancreatic cancer is difficult to treat. Nano-drugs hitching a ride on bacteria could help.
Mice treated with the therapeutic-laden bacteria experienced delayed tumor growth and significantly longer survival compared with mice that received other treatments.
Nanomaterial that mimics proteins could be basis for new neurodegenerative disease treatments
The work centers around altering the interaction between two proteins that are believed to be involved in setting the stage for diseases like Alzheimer's, Parkinson's and amyotrophic lateral sclerosis, or ALS.
Study identifies promising target for treating inflammatory bowel disease and colitis-induced colorectal cancers
Researchers uncovered a previously unknown function of a protein that is central to gut health and implicated in the development of colitis, a severe and chronic form of IBD.
UW–Madison launches PharmD Early Assurance, opening door for more Wisconsin pharmacists
The PharmD Early Assurance program provides conditional admission to the UW–Madison Doctor of Pharmacy (PharmD) program for high school seniors who want to become a pharmacist and are admitted to a four-year UW System university.
New maps show antimicrobial resistance varies within Wisconsin neighborhoods
Mapping variations in antibiotic resistance could help patients receive better informed treatment decisions from their health care providers.
Brain-penetrating drug candidate effective against deadly encephalitis viruses
The multidisciplinary team of researchers found that BDGR-49 protects mice infected with deadly eastern equine encephalitis virus (EEEV) or Venezuelan equine encephalitis virus (VEEV).
Meet the 2023 Distinguished Teaching Award recipients
Twelve faculty members have been chosen to receive this year’s Distinguished Teaching Awards, an honor given out since 1953 to recognize some of the university’s finest educators.
New drug delivery method harnesses clotting to target anti-cancer drugs at tumors
Researchers found that in mice that received the engineered proteins via intravenous injections, the proteins led to clot formation almost exclusively within tumors, with only very limited thrombosis occurring elsewhere.
Health care on the home front: UW grads remain in the state to keep Wisconsin well
Doctors, nurses and pharmacists educated and trained in the UW’s health sciences programs are working in every one of the state’s 72 counties.
First-in-kind psychedelic trials treat opioid and methamphetamine use disorders
School of Pharmacy and School of Medicine and Public Health collaborators are leading two first-in-kind clinical psilocybin trials for treating opioid and methamphetamine use disorders.
Probiotic ‘backpacks’ show promise for treating inflammatory bowel diseases
UW researchers demonstrate just how much promise some well-equipped bacteria hold for improved inflammatory bowel disease treatments.
New injectable gel offers promise for tough-to-treat brain tumors
UW–Madison researchers have developed a powerful immunity-boosting postoperative treatment that could transform the odds for patients with glioblastoma.
Biodegradable gel boosts immune system’s attack on several cancers in mice
The gel, tested in mice, releases drugs and special antibodies that simultaneously deplete immune-blocking cells called macrophages from the surgical site and activate T cells so they can attack cancer.
Nonprescription CBD product labeling largely inaccurate, study finds
UW–Madison School of Pharmacy students concluded that just 15% of CBD-infused oil, beverages and other products are labeled correctly, based on a survey of stores in Southwestern Wisconsin.
Boosting one gene in the brain’s helper cells slows Alzheimer’s progression in mice
High activity of the gene, Nrf2, slowed cognitive and physical decline in the mice and reduced the accumulation of sticky proteins in their brains, all key markers of the disease in humans.
New technique, effective in mice, could help advance the use of probiotics
Researchers in the School of Pharmacy, led by Quanyin Hu, have developed a system that can keep probiotic bacteria alive in the lower intestine long enough to help treat or prevent colitis in a mouse model of the disease.
School of Pharmacy announces master’s program scholarships to address inequities
These scholarships will be awarded to students pursuing a master’s degree in Pharmaceutical Sciences: Applied Drug Development or Psychoactive Pharmaceutical Investigation who demonstrate a financial need and/or have a strong commitment to diversity, equity and inclusion.
UW School of Pharmacy focused on equitable COVID-19 vaccine access
In partnership with the Boys and Girls Club of Dane County, students and employees of the School of Pharmacy are helping sponsor vaccine clinics and town hall discussions to address vaccine hesitancy and concerns.
More than 1,000 students receive tuition credit for providing vaccinations
The nursing and pharmacy students from across the UW System earned a $500 credit while also receiving valuable work experience.